Establish Diagnostic Models Based on Portal Venous Blood for Pancreatic Cancer
ConditionDiagnoses Disease
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorChanghai Hospital
About this trial
Explore new markers based on portal venous blood sampling to establish novel diagnostic models for identification of malignant pancreatic mass.
Eligibility criteria
Qualifiers
age 18-75 years,male or female
diagnosis or suspection of solid pancreatic mass based on previous imaging examination (ultrasonography, CT or MRI)
lesion diameter larger than 1 cm
signed informed consent letter
Disqualifiers
pregnant female
Pancreatic cystic lesions
Anticoagulant/antiplatelet therapy cannot be suspended
unable or refuse to provide informed consent
Trial design
Treatments tested in this trial
- Endoscopic Ultrasound (EUS), Fine Needle Aspiration
Treatment groups
300 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov